Showing results (11-20 of 32) with videos related to
Sort By:
Pageof 4
International Journal of Cancer|April 29, 2006
Chemotherapy pretreatment sensitizes solid tumor-derived cell lines to V alpha 24+ NKT cell-mediated cytotoxicityStephen R Mattarollo, Tony Kenna, Mie Nieda, et al.International Immunopharmacology|October 16, 2012
Synergistic cytotoxicity of ex vivo expanded natural killer cells in combination with monoclonal antibody drugs against cancer cellsXuewen Deng, Hiroshi Terunuma, Mie Nieda, et al.Experimental Dermatology|November 4, 2014
Effective induction of melanoma-antigen-specific CD8+ T cells via Vγ9γδT cell expansion by CD56(high+) Interferon-α-induced dendritic cellsMie Nieda, Hiroshi Terunuma, Yuuta Eiraku, et al.Journal of Leukocyte Biology|May 16, 2006
Comparative gene expression analysis of NKT cell subpopulationsHenry Lin, Mie Nieda, Jonathon F Hutton, et al.International Journal of Oncology|September 6, 2014
Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapyToshiaki Yoshikawa, Masashi Takahara, Mai Tomiyama, et al.Immunology and Cell Biology|July 28, 2006
Efficient priming and expansion of antigen-specific CD8+ T cells by a novel cell-based artificial APCShigemi Sasawatari, Toshimasa Tadaki, Manami Isogai, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 20, 2002
Donor-derived b2a2-specific T cells for immunotherapy of patients with chronic myeloid leukemiaTania Crough, Mie Nieda, James Morton, et al.Journal of Leukocyte Biology|December 25, 2007
Copulsing tumor antigen-pulsed dendritic cells with zoledronate efficiently enhance the expansion of tumor antigen-specific CD8+ T cells via Vgamma9gammadelta T cell activationMasashi Takahara, Manami Miyai, Mai Tomiyama, et al.Anticancer Research|November 2, 2004
A report of three patients treated with immunocell therapy with imatinib mesylateToru Kaneko, Shigenori Goto, Yoshiaki Kushima, et al.Diabetes Research and Clinical Practice|April 27, 2013
A low-grade increase of serum pancreatic exocrine enzyme levels by dipeptidyl peptidase-4 inhibitor in patients with type 2 diabetesHirotake Tokuyama, Harukiyo Kawamura, Masaki Fujimoto, et al.Pageof 4